Más Dermatología, n.º 32

BIBLIOGRAFÍA 1. Guerra-Tapia A. Convivir con los problemas capilares. Madrid: Editorial Médica Panamericana; 2011. 2. Lachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol. 1998;138(3):407-11. 3. Rathnayake D, Sinclair R. Male androgenetic alopecia. Expert Opin Pharmacother. 2010;11(8):1295-304. 4. Johnstone MA, Albert DM. Prostaglandin-induced hair growth. Surv Ophthalmol. 2002;47 Suppl 1:S185-202. 5. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186-94. 6. Hsu CL, Liu JS, Lin AC, Yang CH, Chung WH, Wu WG. Mino- xidil may suppress androgen receptor-related functions. Oncotarget. 2014;5(8):2187-97. 7. Zappacosta AR. Reversal of baldness in a patient receiving mioxidil for hypertension. N Eng J Med. 1980;303(25):1480-1. 8. Tosti A, Camacho-Martínez F, Dawber R. Management of androgenetic alopecia. J Eur Acad Dermatol Venereol. 1999; 12(3):205-14. 9. Gupta AK, Foley KA. 5% Minoxidil: treatment for female pat- tern hair loss. Skin Therapy Lett. 2014;19(6):5-7. 10. Rivera R, Guerra-Tapia A. Management of androgenetic alo- pecia in postmenopausal women. Actas Dermosifilogr. 2008; 99(4):257-61. 11. Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4): 541-53. 12. Guerra-Tapia A, González-Guerra E. Minoxidil. Tratamiento eficaz de la alopecia. Madrid: Editorial IMC; 2016. 13. Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, et al; European Dermatology Forum (EDF). Evidence-based (S3) guideline for the treatment of andro- genetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9 Suppl 6:S1-57. 14. Gargallo V, Gutiérrez C, Vanaclocha F, Guerra-Tapia A. Generalized hypertrichosis due to topical minoxidil. Actas Dermosifiliogr. 2015;106(7):599-600. 15. Gomolin A, Litvinov IV, Netchiporouk E. Oral minoxidil: a possible new therapy for androgenetic alopecia. J Cutan Med Surg. 2020;24(1):88-9. 16. Ramos PM, Sinclair RD, Kasprzak M, Miot HA. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treat- ment of female-pattern hair loss: a randomized clinical trial. J Am Acad Dermatol. 2020;82(1):252-3. 17. Almohanna HM, Perper M, Tosti A. Safety concerns when using novel medications to treat alopecia. Expert Opin Drug Saf. 2018;17(11):1115-28. Guerra-Tapia A et al . Minoxidil tópico o minoxidil oral en la alopecia. ¿Cuál es su elección? Más Dermatol. 2020;32:31-35 doi:10.5538/1887-5181.2020.32.31 35